Loading viewer...
investor_presentation
Format: PDF investor_presentation
Mastercard Incorporated Fourth Quarter and Full Year 2021 Financial Results Conference Call January 27, 2022
Fourth Quarter and Full Year 2021 Financial Results Conference Call
January 27, 2022 ©2022 Mastercard
Michael Miebach:Financial Overview©2022 Mastercard
4th Quarter Selected Financial Performance
($ in millions, except per share data)
4Q 21 4Q 20 YOY Growth
Non-GAAP Non-GAAP As adjusted Currency-neutral
Net revenue $ 5,216 $ 4,120 27% 28%
Adjusted operating expenses 2,389 2,018 18% 19%
Adjusted operating income 2,827 2,102 34% 37%
Adjusted operating margin 54.2 % 51.0 % 3.2 ppt 3.6 ppt
Adjusted net income $ 2,314 $ 1,644 41% 44%
Adjusted diluted EPS $ 2.35 $ 1.64 43% 46%
Adjusted effective tax rate 14.7 % 17.5 %
Note: See Appendix A for Non-GAAP reconciliation.
Thanks, Michael. Turning to page 3 , which shows our financial performance for the quarter on a currency-
neutral basis excluding special items and the impact of gains and losses on our equity investments.
•Net Revenue was up 28% , reflecting the continued execution of our strategy and the ongoing recovery
in spending. Acquisitions contributed 3 ppt to this growth.
•Operating Expenses increased 19% , including a 7 ppt increase from acquisitions.
•Operating Income was up 37% , which includes a 1 ppt decrease related to acquisitions.
•Net Income was up 44% , which includes no impact from acquisitions as the impact of acquisitions on
Operating Income was offset by a one-time acquisition-related tax benefit.
•EPS was up 46% year-over-year to $2.35 cents , which includes a 4 cent contribution from share
•During the quarter, we repurchased $1.3 billion worth of stock and an additional $528 million through
January 24, 2022 . ©2022 Mastercard
$238 $319$560$659$949$1,135
Credit Debit / Prepaid4Q20 4Q21 4Q20 4Q21 4Q20 4Q21$0$200$400$600$800$1,000$1,200$1,400$1,600$1,800Worldwide United States Rest of World
23% Growth 23% Growth 23% Growth
Notes: 1. Growth rates are shown in local currency.
Preview truncated — download the full document for the complete content.
investor_presentation
12 Pages
investor_presentation
25 Pages
MDU Resources
Reviva Pharmaceuticals 2024 Corporate Presentation
investor_presentationinvestor_presentation
38 Pages
Reviva Pharmaceuticals Holdings, Inc.